{
  "meta": {
    "title": "15_Pseudomonas_And_Burkholderiales",
    "url": "https://brainandscalpel.vercel.app/15-pseudomonas-and-burkholderiales-64a867cb.html",
    "scrapedAt": "2025-11-30T12:29:26.767Z"
  },
  "questions": [
    {
      "text": "A 20 year old male presents with acute onset cough and thick sticky sputum. There is a history of repeated lung infections since childhood. Chest Xray shows evidence of bilateral upper lobe bronchiectasis. On evaluation, the chloride concentration in his sweat is >60 mEq/L. What is the organism majorly associated with this patient's respiratory disease?",
      "choices": [
        {
          "id": 1,
          "text": "Burkholderia pseudomallei"
        },
        {
          "id": 2,
          "text": "Pseudomonas putida"
        },
        {
          "id": 3,
          "text": "Pseudomonas aeruginosa"
        },
        {
          "id": 4,
          "text": "Burkholderia cepacia"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Bilateral upper lobe bronchiectasis with a history of repeated lung infections since childhood and evelated sweat chloride concentration suggests a diagnosis of<strong> cystic fibrosis</strong> (CF).<em><strong> Pseudomonas aeruginosa</strong></em> is a common etiological agent associated with <strong>chronic</strong> <strong>airway infection</strong> in patients with cystic fibrosis (CF).</p>\n<p>In cystic fibrosis, there is <strong>thick inspissated mucus</strong> and <strong>impaired mucociliary clearance</strong>. Due to these factors, lungs are often colonized in infancy and early childhood with <em>Staphylococcus aureus</em> and <em>Haemophilus influenzae</em>. In adulthood, they are replaced by <em>P. aeruginosa.</em> This results in chronic inflammation, which leads to airway modelling and bronchiectasis. </p><p>Note: <strong><em>Burkholderia cepacia</em> </strong>complex is an opportunistic environmental pathogen. It causes <strong>fatal respiratory distress</strong> and <strong>septicemia </strong>in <strong>CF</strong> patients. This is termed as 'cepacia syndrome'.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2516",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following organisms causes scombroid fish poisoning?",
      "choices": [
        {
          "id": 1,
          "text": "Salmonella"
        },
        {
          "id": 2,
          "text": "Staphylococcus"
        },
        {
          "id": 3,
          "text": "Pseudomonas aeruginosa"
        },
        {
          "id": 4,
          "text": "Peptostreptococcus"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p class=\"p1\"><strong>Scombroid fish poisoning</strong> is associated with <strong><em>Pseudomonas aeruginosa.</em></strong></p>\n<p class=\"p1\">It follows the consumption of both <strong>scombroid </strong>(mackerel-like) <strong>fish</strong> and nonscombroid fish that have <strong>not</strong> been <strong>refrigerated</strong> properly. The musculature of these dark- or red-fleshed fish <strong>undergoes decomposition</strong> by <em>Morganella morganii, Escherichia coli, Proteus</em> species, <em>Klebsiella</em> species, and <em>Pseudomonas aeruginosa. </em>There is consequent decarboxylation of the amino acid L-histidine to form <strong>histamine</strong>.</p>\n<p class=\"p1\">A second compound is thought to play a causative role in this intoxication because large doses of oral histamine do not reproduce the affliction. The toxin or <strong>toxins involved</strong> are <strong>heat stable</strong> and are not destroyed by cooking or freezing.</p>\n<p class=\"p1\">Symptoms develop within<strong> 15–90 min</strong> of ingestion. Most cases are mild, with <strong>tingling</strong> of <strong>lips</strong> and mouth, mild <strong>abdominal discomfort</strong>, and <strong>nausea</strong>. The more severe and commonly described presentation includes <strong>flushing, </strong>conjunctival hyperemia,<strong> pruritus</strong>, urticaria, and <strong>angioedema</strong>. Without treatment, the symptoms generally <strong>resolve </strong>within<strong> 8–12 h</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3274",
      "difficulty": "medium"
    },
    {
      "text": "A patient comes to the dermatology OPD complaining of greenish discoloration of her nails. You diagnose her with green nail syndrome. Production of which of the following helps differentiate the organism implicated here from other members of its genus?",
      "choices": [
        {
          "id": 1,
          "text": "Pyocyanin"
        },
        {
          "id": 2,
          "text": "Pyoverdin"
        },
        {
          "id": 3,
          "text": "Pyorubin"
        },
        {
          "id": 4,
          "text": "Pyomelanin"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Green nail syndrome</strong> is caused by <strong><em>Pseudomonas aeruginosa.</em></strong> Production of pyocyanin helps differentiate it implicated here from other Pseudomonas species.</p>\n<p><em>Pseudomonas aeruginosa </em>is the only member of the <em>Pseudomonas</em> species that produces <strong>pyocyanin</strong> which is a <strong>bluish-green pigment</strong>. Other species of <em>Pseudomonas</em> also <strong>produce pigments</strong> but they cannot produce pyocyanin. Some of the other pigments produced by<em> Pseudomonas </em>species including <em>P. aeruginosa</em> are <strong>p</strong><strong>yoverdin/flourescein</strong> (greenish-yellow pigment), <strong>pyorubin</strong> (red pigment) and <strong>pyomelanin</strong> (brown pigment).</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2539",
      "difficulty": "medium"
    },
    {
      "text": "The mechanism of action of exotoxin A of Pseudomonas resembles that of _________.",
      "choices": [
        {
          "id": 1,
          "text": "Cholera toxin"
        },
        {
          "id": 2,
          "text": "Diphtheria toxin"
        },
        {
          "id": 3,
          "text": "Tetanus toxin"
        },
        {
          "id": 4,
          "text": "Anthrax toxin"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The action of <strong>exotoxin A</strong> of <strong><em>Pseudomonas aeruginosa</em></strong> is similar to that of the <strong>diphtheria toxin.</strong></p>\n<p>Both exotoxin A and diphtheria toxin cause <strong>ADP ribosylation</strong> of <strong>EF-2</strong> and<strong> </strong>inhibit protein synthesis. Exotoxin A is a single-chain polypeptide with A and B fragments. The B fragment binds the toxin while the A fragment inactivates EF-2 in the presence of nicotinamide adenine dinucleotide (NAD). This leads to the inhibition of polypeptide chain elongation and thus, protein synthesis. </p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/1d1d8461f5bd475687f6a4ebec425f4dx720x581.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Mechanism of action of various bacterial toxins</h3><p>The mechanism of action of various bacterial toxins are as given below:</p>\n<p><span><strong>Increase in&nbsp;</strong></span><strong>cAMP</strong></p>\n<ul>\n<li>Bordetella pertusis</li>\n<li>Bacillus anthracis</li>\n<li>Vibrio cholerae - Cholera toxin</li>\n<li>Enterotoxigenic E.coli (ETEC) - heat labile toxin</li>\n</ul>\n<p><strong>Increase in cGMP</strong></p>\n<ul>\n<li>Enterotoxigenic E.coli (ETEC) - heat stable toxin</li>\n</ul>\n<p><strong>Inhibition of protein synthesis</strong></p>\n<ul>\n<li>Diptheria toxin: inhibit elongation factor-2 (EF-2)</li>\n<li>Pseudomonas: inhibit elongation factor-2 (EF-2)</li>\n<li>Clostridium difficile</li>\n<li>Enterohemorrhagic E.coli (EHEC)-Shiga-like toxin: inhibit 60S</li>\n<li>Shigella dysenteriae-&nbsp;Shiga toxin:&nbsp;inhibit 60S</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2513",
      "difficulty": "easy"
    },
    {
      "text": "A patient with acute onset fever, cough and hemoptysis is diagnosed to have Whitmore's disease. Which of the following organisms causes this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Burkholderia pseudomallei"
        },
        {
          "id": 2,
          "text": "Burkholderia mallei"
        },
        {
          "id": 3,
          "text": "Burkholderia cepacia"
        },
        {
          "id": 4,
          "text": "Paraburkholderia species"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><em><strong>Burkholderia pseudomallei </strong></em>causes <strong>Whitmore's disease.</strong></p>\n<p><strong>Melioidosis</strong> was first described by Whitmore and Krishnaswami. Whitmore isolated the bacillus, and hence, it is known as Whitmore bacillus and melioidosis is called Whitmore's disease. Melioidosis is similar in presentation to <strong>glanders</strong> disease (caused by <em>Burkholderia mallei</em>). Humans are infected tby contact with contaminated soil via skin abrasions. </p>\n<p>Types of melioidosis:</p>\n<ul>\n<li>Acute - It causes <strong>acute pneumonia</strong> with upper lobe infiltrates or severe necrotizing disease. It can also <strong>mimic tuberculosis</strong> with fever, cough, hemoptysis. It may lead to <strong>septicemia</strong>.</li>\n<li>Chronic - It can lead to the development of multiple<strong> caseous</strong> or <strong>suppurative foci</strong>, with skin and <strong>subcutaneous abscesses</strong>. These can lead to <strong>lymphangitis</strong> and <strong>lymphadenopathy</strong>. It may involve bones and other internal organs.</li>\n</ul>\n<p>The bacillus has a <strong>safety-pin appearance </strong>on methylene blue staining. Treatment is divided into two stages: an <strong>intensive </strong>2 week<strong> phase</strong> of <strong>ceftazidime</strong> or a carbapenem followed by at least <strong>12 weeks</strong> of <strong>oral cotrimoxazole</strong> to eradicate the organism and prevent relapse.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2517",
      "difficulty": "medium"
    },
    {
      "text": "A horse-groomer was diagnosed with ulcerative tracheobronchitis. Upon enquiry, it was discovered that one of his horses had recently died of pneumonia after developing a fever and subcutaneous nodules. Which of the following statements is false about the likely causative agent?",
      "choices": [
        {
          "id": 1,
          "text": "It is non-motile."
        },
        {
          "id": 2,
          "text": "It is always oxidase negative"
        },
        {
          "id": 3,
          "text": "It is the causative agent for Glanders disease."
        },
        {
          "id": 4,
          "text": "It induces Strauss reaction on inoculation into guinea pigs."
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The development of ulcerative tracheobronchitis after contact with an infected horse is suggestive of <strong>glanders</strong> which is caused by <em><strong>Burkholderia mallei</strong></em>. It is an <strong>oxidase variable </strong>organism.</p>\n<p>In this case, the horse likely had <strong>glanders,</strong> which presents with fever, pneumonia, and <strong>subcutaneous nodules </strong>called <strong>Farcy buds</strong>. Discharges from the respiratory tract and skin are highly infectious and can be transmitted to humans through close contact (<strong>occupational </strong>route). The horse-groomer likely contracted the infection by the <strong>inhalational route</strong> and developed acute glanders, which is characterised by fever, mucopurulent nasal discharge and ulcerative necrosis of upper respiratory tract (<strong>ulcerative tracheobronchitis</strong>).<strong> </strong>It may lead to septicemia and has a high fatality rate. Percutaneous exposure causes local suppurative skin lesions with associated regional lymphadenopathy.</p>\n<p><em>B. mallei</em> is a <strong>non-motile </strong>Gram-negative bacillus causing Glanders disease. It is an aerobe and a facultative anaerobe. It is oxidase variable i.e. it is usually oxidase negative but may occasionally show a positive reaction. It is a <strong>biosafety level 3</strong> pathogen and so must be handled only in specialised laboratories. When male <strong>guinea pigs</strong> are <strong>inoculated intraperitoneally</strong> with suspected infectious material, it causes <strong>Strauss reaction</strong>. <em>B. mallei</em> sets up a <strong>necrotizing inflammation</strong> in the <strong>scrotal sac</strong> within a few days and can be confirmed bacteriologically. </p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2520",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is Burkholderia cepacia resistant to?",
      "choices": [
        {
          "id": 1,
          "text": "Ceftazidime"
        },
        {
          "id": 2,
          "text": "Trimethoprim-sulfamethoxazole"
        },
        {
          "id": 3,
          "text": "Temocillin"
        },
        {
          "id": 4,
          "text": "Cefotetan"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><em>Burkholderia cepacia</em> is resistant to <strong>cefotetan</strong>.</p>\n<p><strong><em>B. cepacia</em> </strong>complex strains are <strong>intrinsically resistant</strong> to aminoglycosides, polymixin, first and <strong>second-generation cephalosporins </strong>(e.g. cefotetan)<strong> </strong>and carboxypenicillins. This antimicrobial resistance is mediated by efflux pumps, antimicrobial degradation, modifying enzymes or altered membrane functions.</p>\n<p><em>B. cepacia</em> is a Gram-negative bacillus which can cause severe necrotizing pneumonia in patients with chronic granulomatous disease. It can lead to fatal septicemia in patients with <strong>cystic fibrosis</strong>.</p>\n<p class=\"p1\"><strong>Antimicrobial</strong> agents that are <strong>effective</strong> against<strong> </strong><em>B. cepacia</em> complex include meropenem,<strong> ceftazidime, trimethoprim-sulfamethoxazole</strong>, piperacillin and <strong>temocillin.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3191",
      "difficulty": "hard"
    },
    {
      "text": "An organism cultured in Bordet–Gengou medium shows smooth, refractile, glistening colonies resembling 'bisected pearls' or 'mercury drops'. The organism is most likely ______.",
      "choices": [
        {
          "id": 1,
          "text": "Bordetella parapertussis"
        },
        {
          "id": 2,
          "text": "Bordetella bronchiseptica"
        },
        {
          "id": 3,
          "text": "Bordetella pertussis"
        },
        {
          "id": 4,
          "text": "Bordetella petrii"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The organism showing colonies resembling '<strong>bisected pearls</strong>' or '<strong>mercury drops</strong>' on <strong>Bordet-Gengou</strong> medium most likely is <strong><em>Bordetella pertussis</em>. </strong> </p>\n<p>Bordetella pertussis is a Gram-negative coccobacillus. It causes whooping cough or pertussis in children. </p>\n<p>It can be isolated on the enriched medium Bordet-Genou medium (potato-blood-glycerol agar). After incubation for <strong>48 to 72 hours</strong>, <em>B. pertussis</em> colonies are small, dome-shaped, smooth, opaque, viscid, greyish white, refractile, and glistening resembling 'bisected pearls' or 'mercury drops' and are <strong>surrounded</strong> by a hazy zone of <strong>hemolysis</strong>. If growth is confluent, an '<strong>aluminium paint</strong>' appearance is seen. In culture <strong>films</strong>, <em>Bordetella pertussis</em> bacilli tend to be arranged in loose clumps, with clear spaces in between, giving a <strong>'thumbprint' </strong>appearance. </p>\n<p><strong><em>B. parapertussis</em></strong> (option A) grows on <strong>nutrient agar</strong> with the production of a <strong>brown, diffusible pigment</strong> after two days. It also grows more rapidly than <em>B.pertussis</em> on charcoal blood agar.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/5725ac6a567e4d748e443729897ecd6cx1280x1680.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2786",
      "difficulty": "easy"
    },
    {
      "text": "An 8-year-old boy with incomplete vaccination history comes with vomiting after bouts of severe, violent cough. What is the mechanism of action of the toxin responsible for this child's disease? ",
      "choices": [
        {
          "id": 1,
          "text": "Activation of phospholipase and degrades cell membrane"
        },
        {
          "id": 2,
          "text": "Inactivation of  60S ribosome"
        },
        {
          "id": 3,
          "text": "ADP ribosylation and lymphocytosis"
        },
        {
          "id": 4,
          "text": "Activation of guanylate cyclase"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Post-tussive vomiting and bouts of cough in an unimmunized child points to a diagnosis of <strong>pertussis</strong>, caused by <strong><em>Bordetella pertussis</em></strong>. It secretes <strong>pertussis</strong> <strong>toxin</strong> (PT), which acts by <strong>ADP ribosylation </strong>and<strong> </strong>disrupts signal transduction of many cell types. This <strong>promotes lymphocytosis.</strong></p>\n<p>The pertussis toxin disrupts protein synthesis and causes necrosis of parts of the epithelium, leading to pseudomembrane formation. Pertussis toxin also promotes <strong>sensitization to histamine</strong> and <strong>enhances insulin secretion</strong> but these effects have not been demonstrable in patients. They are only seen in experimental animals. </p>\n<p><strong><em>B. pertussis</em></strong> also produces <strong>other toxins</strong> like:</p>\n<ul>\n<li><strong>Adenylate cyclase toxin </strong>(ACT)- It acts by catalysing the production of cAMP by various types of cells and <strong>inhibiting phagocytosis</strong>.</li>\n<li><strong>Heat labile toxin </strong>(HLT)- It is a cytoplasmic protein present in all bordetellae. It is dermonecrotic and lethal in mice. Its pathogenic role is not known.</li>\n<li><strong>Tracheal cytotoxin</strong> (TCT)- It is low molecular weight peptidoglycan which induces ciliary damage in hamster trachea.</li>\n</ul><hr><h3>Related Pearl: Mechanism of action of various bacterial toxins</h3><p>The mechanism of action of various bacterial toxins are as given below:</p>\n<p><span><strong>Increase in&nbsp;</strong></span><strong>cAMP</strong></p>\n<ul>\n<li>Bordetella pertusis</li>\n<li>Bacillus anthracis</li>\n<li>Vibrio cholerae - Cholera toxin</li>\n<li>Enterotoxigenic E.coli (ETEC) - heat labile toxin</li>\n</ul>\n<p><strong>Increase in cGMP</strong></p>\n<ul>\n<li>Enterotoxigenic E.coli (ETEC) - heat stable toxin</li>\n</ul>\n<p><strong>Inhibition of protein synthesis</strong></p>\n<ul>\n<li>Diptheria toxin: inhibit elongation factor-2 (EF-2)</li>\n<li>Pseudomonas: inhibit elongation factor-2 (EF-2)</li>\n<li>Clostridium difficile</li>\n<li>Enterohemorrhagic E.coli (EHEC)-Shiga-like toxin: inhibit 60S</li>\n<li>Shigella dysenteriae-&nbsp;Shiga toxin:&nbsp;inhibit 60S</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2822",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following statements is false about pertussis toxin?",
      "choices": [
        {
          "id": 1,
          "text": "It is expressed on the surface of the bacillus."
        },
        {
          "id": 2,
          "text": "It cannot be toxoided."
        },
        {
          "id": 3,
          "text": "\"A\" portion of A-B structure  is the enzymatically active moiety."
        },
        {
          "id": 4,
          "text": "It is similar to cholera toxin in its structure and function."
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Pertussis toxin</strong> (PT) can be toxoided.</p>\n<p>PT is one of the toxins produced by <em><strong>Bordetella pertussis</strong></em>. It is expressed on the surface of the bacillus and secreted into the surrounding medium. It has an<strong> A-B structure</strong>, the A portion being the enzymatically active moiety and B, the binding component. PT is similar to cholera toxin in its structure and function. PT has <strong>ADP-ribosylating activity</strong> and acts on<strong> inhibitory Gi α subunit</strong> of G-protein coupled receptor (GPCR), whereas cholera toxin acts on stimulatory Gs α subunit of GPCR.</p>\n<p>Pertussis <strong>toxoid</strong> is the major component of the <strong>acellular pertussis vaccine</strong>. A toxoid is a toxin that has lost its toxicity but retains its antigenicity. </p><hr><h3>Related Pearl: Mechanism of action of various bacterial toxins</h3><p>The mechanism of action of various bacterial toxins are as given below:</p>\n<p><span><strong>Increase in&nbsp;</strong></span><strong>cAMP</strong></p>\n<ul>\n<li>Bordetella pertusis</li>\n<li>Bacillus anthracis</li>\n<li>Vibrio cholerae - Cholera toxin</li>\n<li>Enterotoxigenic E.coli (ETEC) - heat labile toxin</li>\n</ul>\n<p><strong>Increase in cGMP</strong></p>\n<ul>\n<li>Enterotoxigenic E.coli (ETEC) - heat stable toxin</li>\n</ul>\n<p><strong>Inhibition of protein synthesis</strong></p>\n<ul>\n<li>Diptheria toxin: inhibit elongation factor-2 (EF-2)</li>\n<li>Pseudomonas: inhibit elongation factor-2 (EF-2)</li>\n<li>Clostridium difficile</li>\n<li>Enterohemorrhagic E.coli (EHEC)-Shiga-like toxin: inhibit 60S</li>\n<li>Shigella dysenteriae-&nbsp;Shiga toxin:&nbsp;inhibit 60S</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2789",
      "difficulty": "medium"
    },
    {
      "text": "A 4-year-old unimmunized child presents with whooping cough. Which of the following constituents of the causative organism is responsible for facilitating its adhesion to the respiratory epithelium?",
      "choices": [
        {
          "id": 1,
          "text": "Adenylate cyclase"
        },
        {
          "id": 2,
          "text": "Lipopolysaccharide"
        },
        {
          "id": 3,
          "text": "Tracheal cytotoxin"
        },
        {
          "id": 4,
          "text": "Filamentous hemagglutinin"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Whooping cough</strong> is caused by <strong><em>Bordetella pertussis.</em></strong> <strong>Filamentous hemagglutinin</strong> (FHA) is responsible for facilitating the <strong>adhesion</strong> of <em>Bordetella pertussis</em> to the <strong>respiratory epithelium.</strong></p>\n<p><em>Bordetella pertussis </em>produces 3 hemagglutinins: Pertussis toxin (PT), lipid factor and FHA. <strong>FHA</strong> is a <strong>surface</strong> protein and is readily shed. Along with fimbrae, it helps in the adhesion of<em> B. pertussis </em>to the <strong>cilia</strong> of the respiratory epithelium and to erythrocytes. FHA and PT also <strong>promote secondary infection</strong> by coating other bacteria such as <strong><em>Haemophilus influenzae</em></strong> and<strong> Pneumococci. </strong>They then<strong> </strong>assists their binding to respiratory epithelium. This phenomenon has been termed '<strong>piracy</strong> of <strong>adhesins'</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2792",
      "difficulty": "medium"
    },
    {
      "text": "What is the incubation period of pertussis in humans?",
      "choices": [
        {
          "id": 1,
          "text": "<7 days"
        },
        {
          "id": 2,
          "text": "3-5 days"
        },
        {
          "id": 3,
          "text": "21-30 days"
        },
        {
          "id": 4,
          "text": "7-14 days"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The <strong>incubation period</strong> of pertussis in humans is <strong>7-14 days.</strong> </p>\n<p>Pertussis is caused by <em>Bordetella pertussis. </em>After the incubation period, the disease takes a <strong>protracted course</strong> comprising <strong>three stages</strong>:</p>\n<ul>\n<li><strong>Catarrhal: </strong>It lasts 1-2 weeks and is characterized by <strong>coryza</strong>, lacrimation, <strong>mild cough</strong>, <strong>low-grade fever</strong>, and malaise.</li>\n<li><strong>Paroxysmal: </strong>It lasts 2-4 weeks with the cough becoming more frequent and spasmodic. The cough comes in repetitive<strong> bursts </strong>of <strong>5–10 </strong>in number, often within a single expiration. <strong>Post-tussive vomiting</strong> is frequent. The episode may be terminated by an <strong>audible whoop</strong>, which occurs upon rapid inspiration against a closed glottis at the end of a paroxysm.</li>\n<li><strong>Convalescent: </strong>It lasts 1–3 months and is characterized by <strong>gradual resolution</strong> of coughing episodes.</li>\n</ul>\n<p>Whooping cough is also known as '<strong>100-day cough</strong>'. For 6–12 months following the illness, <strong>intercurrent viral infections</strong> may be associated with a <strong>recrudescence</strong> of paroxysmal cough.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2794",
      "difficulty": "medium"
    },
    {
      "text": "You are evaluating a 6-year-old unimmunised girl with cough and abdominal pain. Her mother informs you that her daughter has bouts of violent coughing which frequently ends with a loud whoop and is accompanied by vomiting. She gives history of similar complaints in a classmate 2-3 weeks back. Which of the following drugs will you prescribe for this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Erythromycin"
        },
        {
          "id": 2,
          "text": "Penicillin"
        },
        {
          "id": 3,
          "text": "Ciprofloxacin"
        },
        {
          "id": 4,
          "text": "Cotrimoxazole"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given case scenario of <strong>whooping cough</strong>, post-tussive vomiting, and abdominal pain, along with positive history of<strong> exposure</strong> in an <strong>unimmunised</strong> child is suggestive of <strong>pertussis. Erythromycin</strong> or one of the newer macrolides such as azithromycin or clarithromycin is the<strong> drug of choice</strong> for the treatment of this condition.</p>\n<p>Antibiotic therapy in pertussis is used to eradicate the bacteria from the nasopharynx. The treatment is beneficial if it is started within 10 days of the disease. Macrolides are the drugs of choice. Trimethoprim-sulfamethoxazole (Cotrimoxazole) is recommended as an <strong>alternative</strong> for individuals allergic to macrolides. <strong>Macrolides</strong> may also be used in the <strong>chemoprophylaxis</strong> of pertussis. <strong>Post-exposure prophylaxis</strong> is given to household close contacts, and high-risk contacts (infants, immunocompromised, pregnancy).</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2816",
      "difficulty": "medium"
    },
    {
      "text": "A young child with unknown immunization history is suspected to have whooping cough. Which of the following methods will you prefer to use to collect a specimen for culture?",
      "choices": [
        {
          "id": 1,
          "text": "Cough plate method"
        },
        {
          "id": 2,
          "text": "Per-oral swab"
        },
        {
          "id": 3,
          "text": "Per-nasal swab"
        },
        {
          "id": 4,
          "text": "Post-nasal swab"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Whooping cough</strong> is caused by <strong><em>Bordotella pertussis</em></strong>. The <strong>most effective method</strong> for collecting a specimen for the culture of this organism is the <strong>per-nasal</strong> or <strong>nasopharyngeal swab</strong> method. </p>\n<p>Respiratory specimens may be collected for the<strong> culture</strong> (gold standard) of<em> Bordetella pertussis</em> by<strong> </strong>three different methods:</p>\n<ol>\n<li><strong>Per-nasal swab: </strong>A Dacron or rayon tipped swab on a flexible nichrome wire is passed along the floor of the nasal cavity and material is collected from the pharyngeal wall. This specimen is the most <strong>effective</strong> and <strong>best suited</strong> for <strong>diagnostic</strong> procedures.</li>\n<li><strong>Cough plate method: </strong>A culture plate is held about <strong>10 </strong>to <strong>15 cms in front </strong>of the patient's mouth during a bout of cough.</li>\n<li><strong>Post-nasal (peroral) method: </strong>Secretions from the posterior pharyngeal wall are collected with a cotton swab on a bent wire passed through the mouth.</li>\n</ol>\n<p>Other diagnostic tests for pertussis include direct fluorescent aantibody test and PCR on nasopharyngeal specimens. Enzyme immunoassays of antibodies after exposure to <em>B. pertussis</em> can also be used for patients between 2-4 weeks of illness. </p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2813",
      "difficulty": "hard"
    },
    {
      "text": "A pregnant woman comes to the ANC clinic for her 2nd dose of the Tdap vaccine. Which of the following constitutes the acellular component of this vaccine?",
      "choices": [
        {
          "id": 1,
          "text": "Pertactin, filamentous hemaglutinin, and cytotoxin"
        },
        {
          "id": 2,
          "text": "Endotoxin, fimbriae, and pili"
        },
        {
          "id": 3,
          "text": "Pertussis toxoid, cytotoxin, and pili"
        },
        {
          "id": 4,
          "text": "Pertussis toxoid, filamentous hemaglutinin, and fimbrial protein"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Tdap vaccine</strong> is the tetanus, diphtheria and acellular pertussis vaccine. The component of the <strong>acellular pertussis</strong> vaccine is<strong> inactivated pertussis toxin </strong>(PT) and it may contain one or more bacterial components such as<strong> pertactin, filamentous hemagglutinin,</strong> and <strong>fimbrial protein. </strong></p>\n<p><strong>Pertussis vaccine</strong> is usually administered in combination with the toxoids of diphtheria and tetanus (DTaP). <strong>Five doses</strong> of pertussis vaccine are recommended - at <strong>2, 4, 6 </strong>and <strong>15–18 months</strong> of age followed by a <strong>booster</strong> dose at <strong>4–6 years</strong> of age.</p>\n<p>Tdap is now also recommended for <strong>pregnant women</strong> in<strong> between 27 weeks </strong>and <strong>36 weeks</strong> of gestation by the ACOG. This is because infants between the age of 0-2 months are vulnerable to pertussis as they do not begin their vaccine schedule before 6 weeks of age. Thus to protect these infants, placental <strong>transfer </strong>of <strong>maternal pertussis antibodies</strong> has proven to be the most effective approach. Children<strong> under 4 years</strong> who are <strong>contacts</strong> of patients should<strong> receive a booster </strong>even if they had been previously immunized. <strong>Non-immunized contacts</strong> should receive full series of <strong>vaccination</strong> and also<strong> chemoprophylaxis </strong>with<strong> erythromycin</strong> for 10 days after contact with the patient has ceased.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2820",
      "difficulty": "medium"
    }
  ]
}